Epclusa | Velpatasvir And Sofosbuvir Tablet Breastfeeding
Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Epclusa | Velpatasvir And Sofosbuvir Tablet.

What is Epclusa | Velpatasvir And Sofosbuvir Tablet used for?


EPCLUSA is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration (2.2) and Clinical Studies (14)]: without cirrhosis or with compensated cirrhosis with decompensated cirrhosis for use in combination with ribavirin. EPCLUSA is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, and velpatasvir, an HCV NS5A inhibitor, and is indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection (1): without cirrhosis or with compensated cirrhosis with decompensated cirrhosis for use in combination with ribavirin

I am currently breastfeeding and I want to know if using Epclusa | Velpatasvir And Sofosbuvir Tablet is safe for my kid? Does it have any effect on milk production?

Epclusa | Velpatasvir And Sofosbuvir Tablet low risk for breastfeeding
Velpatasvir and Sofosbuvir are the two main ingredients of Epclusa | Velpatasvir And Sofosbuvir Tablet. Based on our individual analysis of Velpatasvir and Sofosbuvir we can safely say that Epclusa | Velpatasvir And Sofosbuvir Tablet has low risk while breastfeeding. Below we have summarized the usage of Velpatasvir and Sofosbuvir while breastfeeding, we recommend you to go through it for better understanding of your usage.

Epclusa | Velpatasvir And Sofosbuvir Tablet Breastfeeding Analsys


Velpatasvir while Breastfeeding

Low Risk

CAS Number: 1377049-84-7

Usually used in combination with sofosbuvir in the treatment of hepatitis C. Since the last update we have not found published data on its excretion in breast milk. Its pharmacokinetic data (high molecular weight and very high percentage of protein binding) make it very unlikely that significant amounts would pass into breast milk, therefore it would not be necessary to stop breastfeeding when taking this medication on its own or in combination with sofosbuvir (Lactmed 2016). See below the information of these related products:

Sofosbuvir while Breastfeeding

Low Risk

CAS Number: 1190307-88-0

Usually used in combination with Ledispavir in the treatment of hepatitis C. Since the last update we have not found published data on its excretion in breast milk. Its pharmacokinetic data (moderately elevated molecular weight, good percentage of protein binding and very short half-life) impedes its passage to breast milk in significant amounts, so although there is disagreement (Thompson 2016), some authors consider that treatment with sofosbuvir, alone or in combination with ledipasvir is not contraindicated during breastfeeding (Spera 2016). See below the information of these related products:


Epclusa | Velpatasvir And Sofosbuvir Tablet Breastfeeding Analsys - 2


Velpatasvir while Breastfeeding

CAS Number: 1377049-84-7

Is Epclusa | Velpatasvir And Sofosbuvir Tablet safe while breastfeeding

Velpatasvir has not been studied in nursing mothers being treated for hepatitis C infection. Because it is greater than 99.5% bound to maternal plasma proteins, amounts in breastmilk are likely to be very low. If velpatasvir used alone or in combination with sofosbuvir is required by the mother, it is not a reason to discontinue breastfeeding. Some sources recommend against breastfeeding when velpatasvir is used with ribavirin. Hepatitis C is not transmitted through breastmilk[1][2] and breastmilk has been shown to inactivate hepatitis C virus (HCV).[3][4] However, the Centers for Disease Control recommends that mothers with HCV infection should consider abstaining from breastfeeding if their nipples are cracked or bleeding. It is not clear if this warning would apply to mothers who are being treated for hepatitis C. Infants born to mothers with HCV infection should be tested for HCV infection; because maternal antibody is present for the first 18 months of life and before the infant mounts an immunologic response, nucleic acid testing is recommended.[1][2]

Sofosbuvir while Breastfeeding

CAS Number: 1190307-88-0 1620486

Sofosbuvir has not been studied in nursing mothers being treated for hepatitis C infection. If sofosbuvir alone or in combination with ledipasvir (Harvoni) is required by the mother, it is not a reason to discontinue breastfeeding.[1] Some sources recommend against breastfeeding when sofosbuvir is used with ribavirin. Hepatitis C is not transmitted through breastmilk[2][3] and breastmilk has been shown to inactivate hepatitis C virus (HCV).[4][5] However, the Centers for Disease Control recommends that mothers with HCV infection should consider abstaining from breastfeeding if their nipples are cracked or bleeding. It is not clear if this warning would apply to mothers who are being treated for hepatitis C. Infants born to mothers with HCV infection should be tested for HCV infection; because maternal antibody is present for the first 18 months of life and before the infant mounts an immunologic response, nucleic acid testing is recommended.[2][3]



I already used Epclusa | Velpatasvir And Sofosbuvir Tablet and meanwhile I breastfed my baby should I be concerned?

Epclusa | Velpatasvir And Sofosbuvir Tablet is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Epclusa | Velpatasvir And Sofosbuvir Tablet so you should inform him based on your convenience.


My health care provider has asked me to use Epclusa | Velpatasvir And Sofosbuvir Tablet, what to do?

Epclusa | Velpatasvir And Sofosbuvir Tablet comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Epclusa | Velpatasvir And Sofosbuvir Tablet, will my baby need extra monitoring?

Not much monitoring required while using Epclusa | Velpatasvir And Sofosbuvir Tablet


Who can I talk to if I have questions about usage of Epclusa | Velpatasvir And Sofosbuvir Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients